VinCense in Makkalai Thedi Maruthuvam Scheme

VinCense & Makkalai Thedi Maruthuvam Scheme

Non-Communicable Diseases(NCDs) caused 55% of the total disease burden in India in 2016, according to the India Health of the Nation’s States study, with the burden of NCDs growing across all States from 1990 to 2016. During the pandemic, the lack of access to health care affected drug compliance and resulted in uncontrolled disease, which had repercussions for the quality of life. Further, those with uncontrolled chronic diseases suffered from higher rates of mortality from Covid 19. It is imperative that nations arm themselves to deal with future epidemics that may develop, and cause similar disruptions in society by adopting the right strategy for NCD screening and management for risk mitigation.

What is Makkalai Thedi Maruthuvam?

The ‘Makkalai Thedi Maruthuvam’ scheme in Tamil Nadu is a community-based intervention aimed at preventing and treating NCDs, as well as addressing the critical concerns of prevention and early diagnosis. It includes population-based screening for ten common conditions in people aged 18 and up, including hypertension, diabetes, oral, cervical, and breast cancers, tuberculosis, leprosy, chronic kidney disease, chronic obstructive pulmonary disease, and mental health, as well as the delivery of hypertension/diabetes drugs to people aged 45 and up, excluding those with limited or poor mobility. The state, which has a high burden of NCDs, also acted on data showing that patients with hypertension (7.3%) and diabetes (10.8%) had very low community control rates (Source: The Hindu).

Why VinCense for Makkalai Thedi Maruthuvam?

In the ‘Makkalai Thedi Maruthuvam’ scheme where Women Health Volunteers go door to door screening for hypertensive and diabetic population, the portable form factor weighing less than 1.5kg, clinical-grade accuracy, speed in capturing the 8 key vital parameters in four minutes, instant alerting and reporting makes VinCense the right fit for this noble and innovative scheme. Even in the most difficult of circumstances, VinCense makes it possible to preserve the continuum of care for the vulnerable population.


VinCense – the award winning IoT, mobility, cloud, analytics mobile health tech platform (patent pending) built around India’s first clinical grade device/wearable that measures pulse rate, oxygen saturation, respiratory rate and skin temperature. Third party wireless devices integrated are NIBP monitor, glucometer, 12 lead ECG and weighing scale, giving 8 parameters in just 4 min (8-in-4) and data are pushed to the cloud through VinCense mobile app, where stakeholders can access real-time actionable data in a user-centered interface. We identify the major metabolic risks early – Cardiovascular, Pulmonary, Diabetic and Obesity. Enabling proactive, personalized data-driven health risk monitoring and management of lifestyle diseases, thereby mitigating the effects of these diseases and reducing the severity of a COVID 19 infection.


VinCense SpotCheck is capable of providing 8 parameters in 4 minutes and the perfect platform for time and cost-effective NCD screening – the principal factor in being able to deliver preventive care for all. Early identification of NCD metabolic risk factors such as raised blood pressure, blood sugar and obesity can be done from the collected vitals by the NCD analytics in the web interface. This will be very useful for the early identification of risk factors which in turn helps in better
treatment outcomes thus enabling preventive and curative care that too at a compelling price point. The health status of the individual can also be tracked. It also helps in population based periodic screening of NCD risk factors -> facilitate early detection -> reduce premature deaths. Thus, our solution is an ideal fit for mass screening and management of Non communicable Diseases.




  • Cost & Time effective
  • Helps in population-based periodic screening of NCD risk factors -> facilitate early detection -> reduce premature deaths
  • Aids preventive care by high volume effective screening and early intervention -> reduce disease burden, DALYs (disability-adjusted life years)
  • Enables NCD surveillance, monitoring and evaluation
  • Enables dialysis at home
  • Elimination of data entry error

For more information, visit or email us at